KR20060034229A - 카랄루마 추출물의 제조방법 및 사용 - Google Patents
카랄루마 추출물의 제조방법 및 사용 Download PDFInfo
- Publication number
- KR20060034229A KR20060034229A KR1020057023343A KR20057023343A KR20060034229A KR 20060034229 A KR20060034229 A KR 20060034229A KR 1020057023343 A KR1020057023343 A KR 1020057023343A KR 20057023343 A KR20057023343 A KR 20057023343A KR 20060034229 A KR20060034229 A KR 20060034229A
- Authority
- KR
- South Korea
- Prior art keywords
- caraluma
- extract
- composition
- solvent
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000284 extract Substances 0.000 title claims abstract description 202
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 194
- 229930182470 glycoside Natural products 0.000 claims abstract description 151
- 238000000605 extraction Methods 0.000 claims abstract description 126
- 239000011347 resin Substances 0.000 claims abstract description 96
- 229920005989 resin Polymers 0.000 claims abstract description 96
- 150000002338 glycosides Chemical class 0.000 claims abstract description 92
- 239000000463 material Substances 0.000 claims abstract description 87
- 238000003801 milling Methods 0.000 claims abstract description 26
- 238000001035 drying Methods 0.000 claims abstract description 24
- 238000002156 mixing Methods 0.000 claims abstract description 24
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 23
- 239000012260 resinous material Substances 0.000 claims abstract description 18
- 238000000227 grinding Methods 0.000 claims abstract description 16
- 230000015556 catabolic process Effects 0.000 claims abstract description 13
- 238000006731 degradation reaction Methods 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000007873 sieving Methods 0.000 claims abstract description 6
- 235000013373 food additive Nutrition 0.000 claims abstract 2
- 239000002778 food additive Substances 0.000 claims abstract 2
- 239000002904 solvent Substances 0.000 claims description 123
- 241000196324 Embryophyta Species 0.000 claims description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 80
- -1 pregnan glycoside Chemical class 0.000 claims description 64
- 239000000203 mixture Substances 0.000 claims description 62
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 60
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 53
- 230000008569 process Effects 0.000 claims description 51
- 241000894007 species Species 0.000 claims description 35
- 239000011877 solvent mixture Substances 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 239000007787 solid Substances 0.000 claims description 22
- 238000001704 evaporation Methods 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 19
- 230000008020 evaporation Effects 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000001814 pectin Substances 0.000 claims description 16
- 229920001277 pectin Polymers 0.000 claims description 16
- 235000010987 pectin Nutrition 0.000 claims description 16
- 239000001648 tannin Substances 0.000 claims description 16
- 229920001864 tannin Polymers 0.000 claims description 16
- 235000018553 tannin Nutrition 0.000 claims description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 15
- 239000002417 nutraceutical Substances 0.000 claims description 15
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 15
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 12
- 229930182490 saponin Natural products 0.000 claims description 12
- 239000011230 binding agent Substances 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical group ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 8
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 230000001754 anti-pyretic effect Effects 0.000 claims description 6
- 239000002221 antipyretic Substances 0.000 claims description 6
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 6
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 6
- 239000001095 magnesium carbonate Substances 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 5
- 206010033546 Pallor Diseases 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 229960004592 isopropanol Drugs 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 240000007472 Leucaena leucocephala Species 0.000 claims description 4
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 4
- 230000001740 anti-invasion Effects 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 4
- WXLJRYSLYQBMGF-RUFGMRSTSA-N CO[C@@H]1[C@@H](O)[C@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C(C)=O)C2)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O Chemical compound CO[C@@H]1[C@@H](O)[C@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C(C)=O)C2)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O WXLJRYSLYQBMGF-RUFGMRSTSA-N 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 239000011343 solid material Substances 0.000 claims description 3
- 241000208327 Apocynaceae Species 0.000 claims description 2
- 208000008589 Obesity Diseases 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 230000004060 metabolic process Effects 0.000 claims description 2
- 235000020824 obesity Nutrition 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000004580 weight loss Effects 0.000 claims description 2
- 229930190237 caratuberside Natural products 0.000 claims 2
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 241000234435 Lilium Species 0.000 claims 1
- 241001125929 Trisopterus luscus Species 0.000 claims 1
- UUPZEAKFTCCJFF-UHFFFAOYSA-N [Cl].[Cl].C=C Chemical group [Cl].[Cl].C=C UUPZEAKFTCCJFF-UHFFFAOYSA-N 0.000 claims 1
- 230000002141 anti-parasite Effects 0.000 claims 1
- 239000003096 antiparasitic agent Substances 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 238000005549 size reduction Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 58
- 241000588724 Escherichia coli Species 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000000543 intermediate Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000607142 Salmonella Species 0.000 description 6
- 241000191940 Staphylococcus Species 0.000 description 6
- 229910001385 heavy metal Inorganic materials 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 5
- 238000011143 downstream manufacturing Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 241000589516 Pseudomonas Species 0.000 description 4
- 229930182478 glucoside Natural products 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000003763 carbonization Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 238000013021 overheating Methods 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 2
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 238000000622 liquid--liquid extraction Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- JWMFYGXQPXQEEM-WZBAXQLOSA-N pregnane group Chemical group [C@@H]12CC[C@H](CC)[C@@]1(C)CC[C@H]1[C@H]2CCC2CCCC[C@]12C JWMFYGXQPXQEEM-WZBAXQLOSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000517186 Caralluma Species 0.000 description 1
- 241001504156 Caralluma adscendens Species 0.000 description 1
- 244000295519 Chimaphila umbellata Species 0.000 description 1
- 241000617429 Clowesia russelliana Species 0.000 description 1
- 240000006560 Coccinia grandis Species 0.000 description 1
- 241000007803 Cuscuta attenuata Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 241000023320 Luma <angiosperm> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000250930 Penicillata Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000020071 rectified spirit Nutrition 0.000 description 1
- 239000012261 resinous substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN451/MAS/2003 | 2003-06-04 | ||
| IN451CH2003 | 2003-06-04 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020077024499A Division KR100993487B1 (ko) | 2003-06-04 | 2004-05-31 | 카랄루마 추출물의 제조방법 및 사용 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20060034229A true KR20060034229A (ko) | 2006-04-21 |
Family
ID=36011983
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057023343A Ceased KR20060034229A (ko) | 2003-06-04 | 2004-05-31 | 카랄루마 추출물의 제조방법 및 사용 |
| KR1020077024499A Expired - Lifetime KR100993487B1 (ko) | 2003-06-04 | 2004-05-31 | 카랄루마 추출물의 제조방법 및 사용 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020077024499A Expired - Lifetime KR100993487B1 (ko) | 2003-06-04 | 2004-05-31 | 카랄루마 추출물의 제조방법 및 사용 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7060308B2 (https=) |
| EP (1) | EP1644013A1 (https=) |
| JP (2) | JP5260873B2 (https=) |
| KR (2) | KR20060034229A (https=) |
| CN (1) | CN1798566B (https=) |
| AU (2) | AU2004244850B2 (https=) |
| BR (1) | BRPI0411400A (https=) |
| CA (1) | CA2527702C (https=) |
| CO (1) | CO5660269A2 (https=) |
| NZ (2) | NZ573614A (https=) |
| WO (1) | WO2004108148A1 (https=) |
| ZA (1) | ZA200509780B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060083795A1 (en) * | 2004-10-19 | 2006-04-20 | Lima Shatkina | Meal replacement products having appetite suppressing qualities |
| KR101307999B1 (ko) * | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
| CA2596311A1 (en) * | 2005-01-20 | 2006-07-27 | Stephen Holt | Herbal compositions containing hoodia |
| WO2007022141A1 (en) * | 2005-08-17 | 2007-02-22 | Charles Tadlock | Delivery system for appetite suppressant |
| CA2660464A1 (en) * | 2006-08-17 | 2008-02-21 | Unilever Plc | Processes for production of hoodia plant extracts containing steroidal glycosides |
| WO2008107910A2 (en) * | 2007-03-05 | 2008-09-12 | Ramaswamy Rajendran | Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same |
| US8247547B2 (en) * | 2009-01-30 | 2012-08-21 | Ghare Vishwas Sadhu | Process for the preparation of Caralluma extract and a formulation prepared thereof |
| US20130122146A1 (en) * | 2011-11-16 | 2013-05-16 | Decas Botanical Synergies, Llc | Process for Spray Drying Botanical Food |
| US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
| US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
| US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
| WO2014178394A1 (ja) | 2013-04-30 | 2014-11-06 | 日本臓器製薬株式会社 | 抽出物及び該抽出物を含有する製剤 |
| EP2810565A1 (en) * | 2013-06-03 | 2014-12-10 | Dupont Nutrition Biosciences ApS | Antioxidant composition |
| CN103969393A (zh) * | 2014-04-25 | 2014-08-06 | 上海相宜本草化妆品股份有限公司 | 用于化妆品中糖苷类中草药化合物含量测试的前处理方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3960839A (en) * | 1973-02-09 | 1976-06-01 | Escuela Politecnica Nacional | Process for recovering and isolating solasodine and glycosides thereof |
| US5270457A (en) * | 1992-06-12 | 1993-12-14 | University Of Manitoba | Cardiac steriod glycosides |
| GB2338235B (en) | 1997-04-15 | 2001-11-14 | Csir | Appetite suppressing plant extracts |
| EP0931550B1 (en) * | 1998-01-26 | 2004-09-22 | National Research Development Corporation, a Government of India Undertaking | A process for the preparation of a spermicidal agent |
| US6703051B1 (en) | 1998-10-13 | 2004-03-09 | Solae, Llc | Process for separating and recovering protein and isoflavones from a plant material |
| US6124442A (en) * | 1999-03-24 | 2000-09-26 | Zhou; James H. | Process for extracting triterpene glycosides from botanical sources |
| US6224906B1 (en) * | 1999-08-31 | 2001-05-01 | Natreon Inc. | St. John's wort composition |
| US6635758B2 (en) * | 2000-09-25 | 2003-10-21 | Industrial Technology Research Institute | Process for extracting glycoside using an aqueous two-phase system |
| EP1448213A2 (en) * | 2001-11-16 | 2004-08-25 | Novartis Nutrition AG | Plant derived or derivable material with appetite suppressant activity |
-
2004
- 2004-05-04 US US10/837,613 patent/US7060308B2/en not_active Expired - Lifetime
- 2004-05-31 BR BRPI0411400-0A patent/BRPI0411400A/pt not_active Application Discontinuation
- 2004-05-31 NZ NZ573614A patent/NZ573614A/en not_active IP Right Cessation
- 2004-05-31 CA CA2527702A patent/CA2527702C/en not_active Expired - Lifetime
- 2004-05-31 EP EP04735495A patent/EP1644013A1/en not_active Ceased
- 2004-05-31 CN CN200480015265.3A patent/CN1798566B/zh not_active Expired - Lifetime
- 2004-05-31 AU AU2004244850A patent/AU2004244850B2/en not_active Expired
- 2004-05-31 NZ NZ543995A patent/NZ543995A/en not_active IP Right Cessation
- 2004-05-31 WO PCT/IN2004/000150 patent/WO2004108148A1/en not_active Ceased
- 2004-05-31 KR KR1020057023343A patent/KR20060034229A/ko not_active Ceased
- 2004-05-31 KR KR1020077024499A patent/KR100993487B1/ko not_active Expired - Lifetime
- 2004-05-31 JP JP2006508488A patent/JP5260873B2/ja not_active Expired - Lifetime
-
2005
- 2005-03-18 US US11/083,226 patent/US7390516B2/en not_active Expired - Lifetime
- 2005-12-01 ZA ZA200509780A patent/ZA200509780B/en unknown
- 2005-12-02 CO CO05122635A patent/CO5660269A2/es not_active Application Discontinuation
-
2008
- 2008-12-12 AU AU2008255233A patent/AU2008255233B2/en not_active Expired
-
2012
- 2012-11-22 JP JP2012256942A patent/JP2013067638A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0411400A (pt) | 2006-07-25 |
| JP2006526615A (ja) | 2006-11-24 |
| US20040247702A1 (en) | 2004-12-09 |
| JP2013067638A (ja) | 2013-04-18 |
| CN1798566B (zh) | 2014-03-12 |
| US7390516B2 (en) | 2008-06-24 |
| KR100993487B1 (ko) | 2010-11-10 |
| NZ573614A (en) | 2011-02-25 |
| EP1644013A1 (en) | 2006-04-12 |
| CO5660269A2 (es) | 2006-07-31 |
| JP5260873B2 (ja) | 2013-08-14 |
| AU2004244850A2 (en) | 2004-12-16 |
| CA2527702A1 (en) | 2004-12-16 |
| US7060308B2 (en) | 2006-06-13 |
| AU2004244850A1 (en) | 2004-12-16 |
| ZA200509780B (en) | 2006-09-27 |
| KR20070114833A (ko) | 2007-12-04 |
| AU2004244850B2 (en) | 2009-01-08 |
| AU2008255233B2 (en) | 2012-01-12 |
| US20050163871A1 (en) | 2005-07-28 |
| NZ543995A (en) | 2009-02-28 |
| CN1798566A (zh) | 2006-07-05 |
| WO2004108148A1 (en) | 2004-12-16 |
| CA2527702C (en) | 2016-03-08 |
| AU2008255233A1 (en) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008255233B2 (en) | Processes for making caralluma extracts and uses | |
| NO172163B (no) | Fremgangsmaate for fremstilling av en krydderekstrakt inneholdende en antioksydant og anvendelse av ekstrakten som antioksydant | |
| CN111117773B (zh) | 一种从蒜头果油中分离神经酸的方法及应用 | |
| CN108743696B (zh) | 具有促进伤口愈合的胆木提取物及其应用 | |
| JP2006526615A5 (https=) | ||
| EP2131681B1 (en) | Process for producing refined nutraceutic extracts from artichoke waste and from other plants of the cynara genus | |
| CN103040882A (zh) | 紫果西番莲茎及叶提取物及其药物组合物与抗抑郁作用 | |
| US10888596B1 (en) | Method of preparing Cannabis extracts | |
| JP3507115B2 (ja) | バナバ葉抽出物と抗糖尿病剤 | |
| CN102872195B (zh) | 一种肉桂总多酚提取物的制备方法及其应用 | |
| CN111499673B (zh) | 一种松果菊苷的制备方法 | |
| HK1197196A1 (en) | Composition of processes for making caralluma extracts | |
| CN110585260A (zh) | 一种单味冻干粉剂及其制备方法 | |
| MXPA05013031A (en) | Processes for making caralluma extracts and uses | |
| KR101548165B1 (ko) | 맛과 향이 증가된 오가피 잎 추출물의 제조방법 및 상기 방법으로 제조된 오가피 잎 추출물 | |
| JPS60123424A (ja) | 茶サポニンを主成分として含む保健剤 | |
| CN121015632A (zh) | 一种具有降血糖功能的茶叶提取物及其制备方法 | |
| EP2835377A1 (en) | Two crystal forms of ginsenoside c-k and method for preparing same | |
| JPS62246591A (ja) | ギムネマ・シルベスタ有効成分抽出物の製造法 | |
| CA3067807A1 (en) | Tongkat ali extract production processes and uses thereof | |
| JPH0458444B2 (https=) | ||
| KR20210037968A (ko) | 인삼열매 액상차의 제조 방법 및 이에 의해 제조된 인삼열매 액상차 | |
| KR20190021735A (ko) | 독활, 두충 및 우슬로부터 생약 추출물을 제조하는 방법 | |
| CN104886594A (zh) | 一种罗汉果复方胶囊的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20051205 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20060120 Comment text: Request for Examination of Application |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070129 Patent event code: PE09021S01D |
|
| A107 | Divisional application of patent | ||
| PA0104 | Divisional application for international application |
Comment text: Divisional Application for International Patent Patent event code: PA01041R01D Patent event date: 20071024 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20080225 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20070129 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |